Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

PF-06835375OngoingRecruitingPhase 2Open NCT05070845 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…